Related Experiment Video
Updated: Feb 17, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Community-Acquired Pneumonia in Children: the Challenges of Microbiological Diagnosis
C M C Rodrigues1,2, H Groves3,4
1Department of Zoology, University of Oxford, Oxford, United Kingdom charlene.rodrigues@gtc.ox.ac.uk.
Insights
Community-acquired pneumonia (CAP) kills many young children worldwide. Better diagnosis of CAP in children requires distinguishing it from other illnesses and identifying the specific germ causing infection.
Area of Science:
- Pediatrics
- Infectious Diseases
- Microbiology
Background:
- Community-acquired pneumonia (CAP) is a major global cause of death in children under five.
- Effective CAP management necessitates differentiating it from other pediatric conditions.
Purpose of the Study:
- To review current diagnostic methods for identifying viral and bacterial pathogens in pediatric respiratory infections.
- To discuss the utility and limitations of these diagnostic modalities for CAP in children.
Main Methods:
- Literature review of diagnostic techniques for respiratory infections in children.
- Analysis of methods for pathogen detection in upper and lower respiratory tracts.
- Discussion of diagnostic test performance and applicability in various settings.
Main Results:
- Various diagnostic tools exist for detecting respiratory pathogens in children.
- Each method presents unique advantages and disadvantages regarding sensitivity, specificity, and practicality.
- Accurate etiological diagnosis is crucial for targeted treatment and resource allocation.
Conclusions:
- Improved diagnostic strategies are essential for optimizing CAP management in children globally.
- Distinguishing CAP and identifying causative agents are key to reducing pediatric mortality.
- Further research into accessible and accurate diagnostic methods is warranted, especially for developing countries.
Abstract:
Community-acquired pneumonia (CAP) is the leading cause of mortality in children under 5 years of age globally. To improve the management of CAP, we must distinguish CAP from other common pediatric conditions and develop better diagnostic methods to detect the causative organism, so as to best direct appropriate resources in both industrialized and developing countries. Here, we review the diagnostic modalities available for identifying viruses and bacteria in the upper and lower respiratory tract of children, with a discussion of their utility and limitations in diagnosing CAP in children.
More Related Videos
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...

